Financial Information

This section of the Zynex Medical InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Zynex Medical assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQZYXI
Beta0.50
Shares Outstanding31.8M
Average Volume (10 days)56.2K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)$0.15
Sales (TTM)$5.79
Book Value (MRQ)$1.12
Cash Flow (TTM)$0.52
Cash (MRQ)$1.18

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy2
 
Buy1
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Daniel J. Moorhead
CHIEF FINANCIAL OFFICER
5,000
Acquire
Dec 5, 2024
Daniel J. Moorhead
CHIEF FINANCIAL OFFICER
(4,879)
Dispose
Dec 5, 2024
Daniel J. Moorhead
CHIEF FINANCIAL OFFICER
(10,000)
Sell
Dec 2, 2024
Thomas Sandgaard
PRESIDENT, CEO AND CHAIRMAN
(2,000)
Sell
Nov 14, 2024
Thomas Sandgaard
PRESIDENT, CEO AND CHAIRMAN
(2,000)
Sell
Nov 13, 2024

Recent SEC Filings

4
Insider Buy/Sell
Dec 6, 2024
4
Insider Buy/Sell
Dec 3, 2024
4
Insider Buy/Sell
Nov 18, 2024
4
Insider Buy/Sell
Nov 13, 2024
4
Insider Buy/Sell
Nov 6, 2024
Currency in USD.
Quote data delayed by at least 15 minutes.
Earnings and Analyst data provided by Zacks.
Insiders data provided by Morningstar.